Enteral Nutrition Education Provided Using the Pecha Kucha Method

April 6, 2026 updated by: SERAP GÜNGÖR ÜNAL, Kahramanmaras Sutcu Imam University

Short-Term and Long-Term Effects of Enteral Nutrition Education Provided Via the Pecha Kucha Method on Self-Efficacy Levels of Intensive Care Nurses Regarding Enteral Nutrition Practices

Enteral nutrition therapy is essential to prevent or treat malnutrition, reduce infection complications, shorten recovery and hospital stay, and lower hospital costs and mortality rates. Intensive care nurses have responsibilities including diagnosing nutritional deficiencies, preventing complications, and implementing and maintaining enteral nutrition. In recent years, there has been increased interest in innovative teaching methods in the educational literature that enhance learners' attention, reduce cognitive load, and enable effective learning in a short time. The Pecha-Kucha method is a contemporary educational approach that aims to present information concisely and effectively thanks to its visually-oriented and time-limited structure. This study aims to fill this important gap in the literature and provide evidence-based contributions to applicable educational approaches in intensive care settings by revealing the short-term and long-term effects of enteral nutrition education given using the Pecha-Kucha method on the self-efficacy levels of intensive care nurses regarding enteral nutrition.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Sanliurfa, Turkey (Türkiye)
        • Şanlıurfa Mehmet Akif İnan Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The nurses who participated in the study were those who had been working in the intensive care unit of Şanlıurfa Mehmet Akif İnan Training and Research Hospital for at least one month between the study dates and who agreed to participate.

Description

Inclusion Criteria:

  • It will consist of nurses who are over 18 years of age,
  • Have been actively working in an intensive care unit for at least 1 month,
  • Who volunteer to participate in the research and training.

Exclusion Criteria:

  • Nurses who are on unpaid or maternity leave during training,
  • Do not wish to volunteer for research and training will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Efficacy in Enteral Nutrition Practices
Time Frame: 2 weeks and 8 weeks
The scale, developed to measure nurses' self-efficacy in enteral nutrition practices, consists of two sub-factors and 37 items. The five-point Likert scale is evaluated on a scale of "strongly disagree (1)" to "strongly agree (5)". The Knowledge Sub-Factor consists of 20 items (items 1-20); the Practice Sub-Factor consists of 17 items (items 21-37). There are no reverse items in the scale. The minimum total score obtainable from the scale is 37, and the maximum is 185. The minimum-maximum scores for the Knowledge sub-factor are 20-100; the minimum-maximum scores for the Practice sub-factor are 17-85. As the scores obtained from the entire scale and its sub-factors increase, it is inferred that self-efficacy levels in enteral nutrition practices increase. The Cronbach's alpha coefficients for the sections of the scale are 0.92 and 0.91, respectively. The Chronbach Alpha coefficient for the entire scale is 0.94.
2 weeks and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kahramanmaras Sutcu Imam University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2026

Primary Completion (Estimated)

April 6, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

March 30, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 9, 2026

Last Update Submitted That Met QC Criteria

April 6, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Pecha Kucha
  • University (Other Identifier: Kahramanmaras Sutcu Imam University, SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Training

Clinical Trials on Pecha Kucha Method Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe